The EU introduction of mitotane [Lysodren; HRA Pharma] 500mg tablets is to go ahead once pricing and reimbursement issues have been settled
Source: Inpharma, Volume 1, Number 1442, 2004-06-19 , pp. 18-18(1)
Publisher: Adis International
Keywords: Mitotane, therapeutic use; Product-approvals
Document Type: Short communication
Publication date: 2004-01-01
- In this: publication
- By this: publisher
- In this Subject: Pharmacology

Shopping cart
Receive new issue alert
Get Permissions